Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.010
+0.152 (17.73%)
At close: Jan 6, 2026, 4:00 PM EST
1.080
+0.070 (6.93%)
After-hours: Jan 6, 2026, 7:25 PM EST
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $32.38 million as of January 6, 2026. Its market cap has decreased by -67.16% in one year.
Market Cap
32.38M
Enterprise Value
-1.65M
1-Year Change
-67.16%
Ranking
Category
Stock Price
$1.01
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $32.38M, a decrease of -90.91%. That is a compound annual growth rate of -74.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 27.50M | 14.58% |
| Dec 31, 2025 | 24.00M | -72.06% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |